Basel Medical Group Ltd is a holding company, which operates through its subsidiary, Basel Medical Group Pte. Ltd. It provides a wide spectrum of general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Its orthopedic treatments and surgery include non-surgical treatments, such as medications, injections, splinting and physiotherapy, and surgical orthopedic procedures, including minimally invasive treatments for complex surgeries. Its rehabilitative therapy provides in-house physiotherapy treatments, including post-surgery rehabilitation, as well as sports therapy. Its neurosurgical care covers treatments involving spinal and brain conditions, from headaches and brain tumors to spinal issues, aneurysms and strokes. It also specializes in diagnostic imaging and outpatient care.
企業コードBMGL
会社名Basel Medical Group Ltd
上場日Feb 25, 2025
最高経営責任者「CEO」Chhoa (Yen Feng)
従業員数77
証券種類Ordinary Share
決算期末Feb 25
本社所在地600 North Bridge Road, #12-02/03
都市
証券取引所NASDAQ OMX - NASDAQ BASIC
国Singapore
郵便番号188778
電話番号6562919188
ウェブサイトhttps://www.baselmedical.com
企業コードBMGL
上場日Feb 25, 2025
最高経営責任者「CEO」Chhoa (Yen Feng)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし